AbstractHIVRSVInternational Workshop on HIV & Women 2019Women’s Involvement in Clinical Research: Women Included in Dolutegravir Clinical Trials Versus Collaborative StudiesView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Vaginal Microbiome and Associations with Tenofovir Diphosphate and Lamivudine Triphosphate in Cervical Tissues of Ugandan WomenView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Intimate Partner Violence, Depression, and Mortality Among a Cohort of Women Living with HIV Marginalized by Socio-Structural Inequities in Vancouver, CanadaView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Dolutegravir Pharmacokinetics During Pregnancy and PostpartumView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Non-Vaccine Oncogenic HPV Persistence Among HPV-Vaccinated Women Living with HIVView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Innovative Intervention for Pregnant and Breastfeeding Adolescent Mothers to Enhance Viral Suppression in Homa Bay County, KenyaView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019High PrEP Uptake Among HIV-Exposed Women with Pregnancy Plans in South AfricaView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Optimizing HIV Service Delivery for Young Women Who Sell Sex: A Discrete Choice ExperimentView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019HIV Risk and Characteristics of Women Seeking PrEP in a US Demonstration ProjectView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Clinical Development Strategy to Inform Dosing of Antiretroviral Drugs in Women: Dolutegravir as a Case StudyView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Evaluation of Neural Tube Defects After Exposure to Raltegravir During PregnancyView Abstract
AbstractHIVRSVInternational Workshop on HIV & Women 2019Congenital Anomalies in Infants of Canadian Women Exposed to Antiretrovirals, Including DolutegravirView Abstract
